We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Off-Label Guide Could Prompt Re-Evaluation Of Public Presentation Policies

27 January 2012

Daily News
Washington D.C. partner Meredith Manning is quoted in the InsideHealthPolicy.com article, “Off-Label Guide Could Prompt Re-Evaluation Of Public Presentation Policies,” regarding a recent Food and Drug Administration (FDA) guidance on drug promotion and requests for off-label information. Click the link above to read the article.

The team

Loading data